Skip to main content
SpringerLink
Log in

HZ subunit vaccine good value versus live HZ vaccine

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 US dollars

References

  1. Le P, et al. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. JAMA Internal Medicine : 2 Jan 2018. Available from: URL: http://doi.org/10.1001/jamainternmed.2017.7431.

  2. Najafzadeh M. Evolution of Herpes Zoster Vaccines and Their Economic Value. JAMA Internal Medicine : 2 Jan 2018. Available from: URL: http://doi.org/10.1001/jamainternmed.2017.7442.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HZ subunit vaccine good value versus live HZ vaccine. PharmacoEcon Outcomes News 794, 15 (2018). https://doi.org/10.1007/s40274-018-4613-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4613-z

Search

Navigation